Troriluzole is an experimental medication that has been investigated as a potential treatment for Machado–Joseph disease, obsessive–compulsive disorder, and glioblastoma. It is a prodrug formulation of the medication riluzole. From Wikipedia
The Connecticut case claims the company misled the market on the prospects of two key drug programs.
